Trial Profile
Effects of Neuromuscular Block Reversal With Sugammadex vs Neostigmine on Postoperative Respiratory Outcomes After Major Abdominal Surgery - A Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2019
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Atropine; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- Sponsors Merck & Co
- 14 Jun 2019 As per NCT and Eudra, the trail is open label, however, result source have reported blinded for the patient and the researcher testing pulmonary function and Reversal medications were unblinded to the anesthesiologist in the operating room. researcher testing pulmonary function was not associated with administration of study drugs. As anesthesiologist was unblinded and patients were blinded I have added "single blind"
- 04 Jun 2019 Primary endpoint has not been met. (Change from baseline in FVC at 1h after surgery), as reported in an article published in the Canadian Journal of Anesthesia.
- 04 Jun 2019 Results published in the Canadian Journal of Anesthesia